Showing results (511-520 of 1,056) with videos related to
Sort By:
Pageof 106
Food Chemistry: X|March 19, 2026
Modification of nanocellulose filler via amination and subsequent grafting of gallic acid for enhancing the performance of biodegradable soy protein films in banana packagingYan Zhu, Haizhu Wu, Weijia Yang, et al.Cells|April 3, 2021
Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic IssuesMorgane Lallier, Louise Marchandet, Brice Moukengue, et al.Peerj|February 23, 2022
Characterizing the suckling behavior by video and 3D-accelerometry in humpback whale calves on a breeding groundMaevatiana N Ratsimbazafindranahaka, Chloé Huetz, Aristide Andrianarimisa, et al.Lung Cancer (Amsterdam, Netherlands)|March 25, 2022
Prognostic impact of inflammation in malignant pleural mesothelioma: A large-scale analysis of consecutive patientsLudovic Fournel, Thomas Charrier, Maxime Huriet, et al.Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|July 11, 2009
In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary culturesDavid M Dohan Ehrenfest, Antoine Diss, Guillaume Odin, et al.Archives of Oral Biology|February 24, 2010
Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent wayDavid M Dohan Ehrenfest, Pierre Doglioli, Giuseppe M de Peppo, et al.BMC Bioinformatics|April 7, 2018
Linear MALDI-ToF simultaneous spectrum deconvolution and baseline removalVincent Picaud, Jean-Francois Giovannelli, Caroline Truntzer, et al.International Journal of Cancer|February 15, 2001
Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifierC M Maugard, J Charrier, A Pitard, et al.Neuron|November 10, 2019
Trans-Synaptic Signaling through the Glutamate Receptor Delta-1 Mediates Inhibitory Synapse Formation in Cortical Pyramidal NeuronsMatteo Fossati, Nora Assendorp, Olivier Gemin, et al.Anti-Cancer Drug Design|April 1, 1994
Chemotherapeutic inhibition of erb-B2 oncogene expression on a non-small-cell cancer line (NSCLC-N6) by marine substancesC Roussakis, J Charrier, D Riou, et al.Pageof 106